Skip to content
Browse

Edition

Sections

Appearance

AboutSourcesContactPrivacy

U.S. FDA issues VAI classification to Natco Pharma’s FDF unit in Vizag

VAI is one of the three classifications, the U.S. FDA issues implying objectionable conditions or practices were found, during the inspection, but the regulator is not prepared to take or recommend any administrative or regulatory action

First reported by The Hindu 1 source
Image: The Hindu
Image: The Hindu
Read at The Hindu(opens in a new tab)

Full coverage

Every report we found on this story, oldest first. Each links to the original publisher.

  1. The Hindu

    U.S. FDA issues VAI classification to Natco Pharma’s FDF unit in Vizag (opens The Hindu in a new tab)

    VAI is one of the three classifications, the U.S. FDA issues implying objectionable conditions or practices were found, during the inspection, but the regulator is not prepared to take or recommend any administrative or regulatory action

Something wrong with how we've grouped or summarised this story? Report a problem